Peptidoglycan endopeptidase MepM of uropathogenic Escherichia coli contributes to competitive fitness during urinary tract infections

Wen-Chun Huang,Ida Bagus Nyoman Putra Dwija,Masayuki Hashimoto,Jiunn-Jong Wu,Ming-Cheng Wang,Cheng-Yen Kao,Wei-Hung Lin,Shuying Wang,Ching-Hao Teng
DOI: https://doi.org/10.1186/s12866-024-03290-9
IF: 4.465
2024-05-31
BMC Microbiology
Abstract:Urinary tract infections (UTIs) are common bacterial infections, primarily caused by uropathogenic Escherichia coli (UPEC), leading to significant health issues and economic burden. Although antibiotics have been effective in treating UPEC infections, the rise of antibiotic-resistant strains hinders their efficacy. Hence, identifying novel bacterial targets for new antimicrobial approaches is crucial. Bacterial factors required for maintaining the full virulence of UPEC are the potential target. MepM, an endopeptidase in E. coli , is involved in the biogenesis of peptidoglycan, a major structure of bacterial envelope. Given that the bacterial envelope confronts the hostile host environment during infections, MepM's function could be crucial for UPEC's virulence. This study aims to explore the role of MepM in UPEC pathogenesis.
microbiology
What problem does this paper attempt to address?